Core G: University of Kentucky Alzheimer's Disease Core Center
Core G: University of Kentucky Alzheimer's Disease Core Center
批准号:
10261968
负责人:
LINDA J VAN ELDIK
金额:
$12.01万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
2021
资助国家:
美国
项目状态:
未结题
起止时间:
2021-08-01 至 2026-06-30
关键词:
AchievementAddressAdvisory CommitteesAlzheimer&aposs DiseaseAlzheimer&aposs Disease Core CenterAlzheimer&aposs disease related dementiaAreaBasic ScienceBehavioralBiological MarkersClinicalClinical ResearchClinical Trials DesignCommunitiesCompetenceCustomData AnalysesDementiaDevelopmentDisciplineEarly DiagnosisEducationEducational ActivitiesElderlyEnvironmentEtiologyExposure toFacultyFoundationsFundingFutureGoalsImageIndividualInterdisciplinary StudyKentuckyKnowledgeLeadershipLearningLiquid substanceMagnetic Resonance ImagingMentorsMonitorNCI Scholars ProgramOutcomeParticipantPostdoctoral FellowPrevention ResearchProcessProgram DevelopmentRecording of previous eventsResearchResearch DesignResearch PersonnelResearch Project GrantsResourcesScienceScientistStandardizationStructureSystemTeacher Professional DevelopmentTrainingTraining ProgramsTranslational ResearchUniversitiescareercareer developmentcollaborative environmenteducation researchexperiencehealth inequalitieshealth literacyhigh schoolimprovedinnovationinstrumentinvestigator traininglongitudinal analysismixed dementiamultidisciplinaryneuropathologynext generationnovelpreventprofessorprogramsrecruitskill acquisitionskillssuccesstherapy developmenttraining opportunitytreatment researchundergraduate student
中文摘要
点击翻译按钮获取中文摘要
英文摘要
Project Summary/Abstract: Research Education Component
The Research Education Component (REC) of the UK-ADRC offers a variety of research educational activities
and comprehensive, mentored research skills development programs that will enhance the development of the
future workforce to meet the nation’s biomedical, behavioral, and clinical needs in Alzheimer’s disease and
related dementias (ADRD) research. The REC will leverage resources within and outside the UK-ADRC to
create an outstanding, multidisciplinary, and collaborative environment for training the next generation of
researchers in scientific areas that parallel the theme of our ADRC (Transitions from Normal to Late-Life, Multi-
Etiology Dementias), and with an emphasis on increasing representation of researchers from diverse
backgrounds. We will continue to build on a long history of collaborative and dedicated faculty, a strong
foundation in multidisciplinary team science, and an outstanding track record of success in mentoring and
education of researchers across the training spectrum. We will also establish a new REC Scholar program
aimed at junior investigators (Assistant Professors, senior research associates, or clinical fellows). This
program will support junior investigators from diverse, multidisciplinary fields to pursue mentored basic,
translational, or clinical research in ADRD, and follow a customized training plan to help the scholars move
toward their career development goals. This training will be done in a supportive and collaborative academic
environment with substantial training resources and an experienced and dedicated training faculty. Scholars
will have the opportunity to learn state-of-the-art research skills in disciplines that have been identified as
critically needed areas for the ADRC workforce of the future. Examples of training areas where the UK-ADRC
has strong expertise include analysis of longitudinal clinical outcomes, clinical trial design, MRI imaging and
novel fluid biomarkers, quantitative neuropathology and AD mimics, data analysis/ study design in mixed
dementias, and health literacy and inequities. REC goals will involve interactions with all the UK-ADRC Cores
and will be achieved through the following specific aims.
Aim 1. Provide education programs and research skills development opportunities for investigators at UK.
Aim 2. Identify, select, support, and retain REC scholars from diverse backgrounds and disciplines to engage
in ADRD research.
Aim 3. Develop an individualized mentoring plan and educational program for each REC scholar to enable
advancement to independent research and funding in ADRD research.
Aim 4. Evaluate progress of the REC scholars, address barriers towards the goal of independence in ADRD
research and refine delivery of the program’s educational structure and processes.
Following completion of the Program, participants will have the knowledge, expertise, and confidence to
successfully pursue a long-term career in dementia research.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
GMP Production and Extended Toxicology of an Oral Formulation Drug for Alzheimer's Disease
-
批准号:10624841
-
项目类别:
-
资助金额:$154.73万
-
财政年份:2022
-
负责人:LINDA J VAN ELDIK
-
依托单位:
Portable and modular UDS Data Collection software to increase collaboration and engagement of Alzheimer’s Disease Research Center research software engineers
-
批准号:10608722
-
项目类别:
-
资助金额:$22.93万
-
财政年份:2021
-
负责人:LINDA J VAN ELDIK
-
依托单位:
Core A: University of Kentucky Alzheimer's Disease Core Center
-
批准号:10261962
-
项目类别:
-
资助金额:$35.53万
-
财政年份:2021
-
负责人:LINDA J VAN ELDIK
-
依托单位:
University of Kentucky Alzheimer's Disease Research Center
-
批准号:10662314
-
项目类别:
-
资助金额:$288.09万
-
财政年份:2021
-
负责人:LINDA J VAN ELDIK
-
依托单位:
Core G: University of Kentucky Alzheimer's Disease Core Center
-
批准号:10662371
-
项目类别:
-
资助金额:$16.33万
-
财政年份:2021
-
负责人:LINDA J VAN ELDIK
-
依托单位:
Core A: University of Kentucky Alzheimer's Disease Core Center
-
批准号:10662339
-
项目类别:
-
资助金额:$27.88万
-
财政年份:2021
-
负责人:LINDA J VAN ELDIK
-
依托单位:
Core A: University of Kentucky Alzheimer's Disease Core Center
-
批准号:10459466
-
项目类别:
-
资助金额:$27.88万
-
财政年份:2021
-
负责人:LINDA J VAN ELDIK
-
依托单位:
Core G: University of Kentucky Alzheimer's Disease Core Center
-
批准号:10459472
-
项目类别:
-
资助金额:$16.33万
-
财政年份:2021
-
负责人:LINDA J VAN ELDIK
-
依托单位:
University of Kentucky Alzheimer's Disease Research Center
-
批准号:10459464
-
项目类别:
-
资助金额:$293.7万
-
财政年份:2021
-
负责人:LINDA J VAN ELDIK
-
依托单位:
University of Kentucky Alzheimer's Disease Research Center
-
批准号:10261961
-
项目类别:
-
资助金额:$300.99万
-
财政年份:2021
-
负责人:LINDA J VAN ELDIK
-
依托单位:
First-in-human SAD & MAD trials for MW151, a novel Alzheimer's disease drug candidate that attenuates proinflammatory cytokine dysregulation
-
批准号:10307828
-
项目类别:
-
资助金额:$33.66万
-
财政年份:2019
-
负责人:LINDA J VAN ELDIK
-
依托单位:
First-in-human SAD & MAD trials for MW151, a novel Alzheimer's disease drug candidate that attenuates proinflammatory cytokine dysregulation
-
批准号:10061521
-
项目类别:
-
资助金额:$119.36万
-
财政年份:2019
-
负责人:LINDA J VAN ELDIK
-
依托单位:
Preclinical Development of a Selective Suppressor of Neuroinflammation for MCI/AD
-
批准号:9272346
-
项目类别:
-
资助金额:$146.89万
-
财政年份:2015
-
负责人:LINDA J VAN ELDIK
-
依托单位:
Microglia responses to CNS injury: targeting p38 MAPK signaling
-
批准号:8985734
-
项目类别:
-
资助金额:$32.9万
-
财政年份:2015
-
负责人:LINDA J VAN ELDIK
-
依托单位:
Microglia responses to CNS injury: targeting p38 MAPK signaling
-
批准号:9265338
-
项目类别:
-
资助金额:$32.92万
-
财政年份:2015
-
负责人:LINDA J VAN ELDIK
-
依托单位:
Microglia responses to CNS injury: targeting p38 MAPK signaling
-
批准号:9059183
-
项目类别:
-
资助金额:$32.92万
-
财政年份:2015
-
负责人:LINDA J VAN ELDIK
-
依托单位:
Preclinical Development of a Selective Suppressor of Neuroinflammation for MCI/AD
-
批准号:9134677
-
项目类别:
-
资助金额:$140.34万
-
财政年份:2015
-
负责人:LINDA J VAN ELDIK
-
依托单位:
Preclinical Development of a Selective Suppressor of Neuroinflammation for MCI/AD
-
批准号:8944142
-
项目类别:
-
资助金额:$141.63万
-
财政年份:2015
-
负责人:LINDA J VAN ELDIK
-
依托单位:
Modulation of CNS Proinflammatory Cytokine Production
-
批准号:7888622
-
项目类别:
-
资助金额:$29.24万
-
财政年份:2010
-
负责人:LINDA J VAN ELDIK
-
依托单位:
Modulation of CNS Proinflammatory Cytokine Production
-
批准号:8269733
-
项目类别:
-
资助金额:$28.65万
-
财政年份:2010
-
负责人:LINDA J VAN ELDIK
-
依托单位:
海外基金